WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.50
+0.50 (1.25%)
Feb 16, 2026, 12:08 PM HKT

WuXi Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
167,57072,100124,993252,882390,943419,914
Market Cap Growth
124.25%-42.32%-50.57%-35.32%-6.90%228.81%
Enterprise Value
163,93371,052122,776247,673380,146418,224
Last Close Price
40.5017.5629.6059.8592.55102.80
PE Ratio
37.3920.1933.3750.6193.99209.36
Forward PE
27.9317.0922.7137.4177.91168.15
PS Ratio
7.633.636.6614.6530.9563.00
PB Ratio
3.121.492.586.189.7416.92
P/TBV Ratio
3.561.702.966.7910.5617.69
P/FCF Ratio
86.9352.62182.37---
P/OCF Ratio
26.7312.9924.3140.3792.82187.95
PEG Ratio
1.331.991.391.021.993.92
EV/Sales Ratio
7.463.586.5414.3530.1062.75
EV/EBITDA Ratio
21.5011.4222.6143.2285.50198.82
EV/EBIT Ratio
27.2514.5628.3450.3697.69234.41
EV/FCF Ratio
85.0451.85179.13---
Debt / Equity Ratio
0.100.110.100.120.130.16
Debt / EBITDA Ratio
0.730.820.890.861.181.85
Debt / FCF Ratio
2.903.847.33---
Net Debt / Equity Ratio
-0.15-0.13-0.15-0.12-0.21-0.25
Net Debt / EBITDA Ratio
-1.09-0.99-1.36-0.85-1.89-2.91
Net Debt / FCF Ratio
-4.22-4.48-10.7413.142.221.24
Asset Turnover
0.340.330.320.330.280.24
Inventory Turnover
6.366.715.044.313.944.15
Quick Ratio
2.401.982.351.561.852.49
Current Ratio
2.882.732.781.982.373.16
Return on Equity (ROE)
10.51%8.82%8.90%13.20%13.09%10.02%
Return on Assets (ROA)
5.89%5.05%4.63%5.81%5.43%4.03%
Return on Invested Capital (ROIC)
10.55%9.71%9.72%12.78%13.38%10.74%
Return on Capital Employed (ROCE)
10.60%9.50%8.00%10.80%8.90%6.10%
Earnings Yield
2.74%4.95%3.00%1.98%1.06%0.48%
FCF Yield
1.15%1.90%0.55%-0.15%-0.97%-1.17%
Buyback Yield / Dilution
2.55%2.80%0.62%1.04%-5.05%-5.30%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.